Tags :2-18

2-18 age group: DCGI approves Phase 3 clinical trial of COVAXIN

Nation

2-18 age group: DCGI approves Phase 3 clinical trial of

Editor canara May 13, 2021

DCGI approves Phase II/III clinical trial of COVAXIN in the age group of 2 to 18 Years Read More

© 2022, The Canara Post. Website designed by The Web People.

error: Content is protected !!